Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The T-cell Lymphoma Master Repository (TCLMR): A Prospective Databank of Patients With T-cell Lymphoma With Clinical Annotation and Matched Tumor Specimens

NCT05978141 is registered in ClinicalTrials.gov with Memorial Sloan Kettering Cancer Center as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05978141 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The T-cell Lymphoma Master Repository (TCLMR): A Prospective Databank of Patients With T-cell Lymphoma With Clinical Annotation and Matched Tumor Specimens
Lead sponsor
Memorial Sloan Kettering Cancer Center
Phase
Observational
Overall status
Recruiting
Start date
July 27, 2023
Completion date
July 27, 2030
Enrollment
1,000 (estimated)
Sites
26

Conditions

As the registry lists them; a condition with its own page is linked.

adult t-cell leukemia/lymphoma, aggressive nk-cell leukemia, anaplastic large cell lymphoma, alk-negative, anaplastic large cell lymphoma, alk-positive, angioimmunoblastic t-cell lymphoma, breast implant-associated anaplastic large cell lymphoma, chronic active ebv infection of t-and nk-cell type, systemic form, chronic lymphoproliferative disorder of nk cells, enteropathy-associated t-cell lymphoma, extranodal nk/t-cell lymphoma, nasal type, follicular t-cell lymphoma, hepatosplenic t-cell lymphoma, hydroa vacciniforme-like lymphoproliferative disorder, indolent t-cell lymphoproliferative disorder of the gastrointestinal tract, intestinal t-cell lymphoma, not otherwise specified, monomorphic epitheliotropic intestinal t-cell lymphoma, mycosis fungoides, nk-cell lymphoma, nodal peripheral t-cell lymphoma with tfh phenotype, peripheral t-cell lymphoma, not otherwise specified, primary cutaneous acral cd8-positive t-cell lymphoma, primary cutaneous anaplastic large cell lymphoma, primary cutaneous cd8-positive aggressive epidermotropic t-cell lymphoma, primary cutaneous t-cell lymphoma, sezary syndrome, subcutaneous panniculitis-like t-cell lymphoma, systemic epstein barr virus positive t-cell lymphoproliferative disease of childhood, systemic epstein-barr virus positive t-cell lymphoproliferative disease of childhood (disorder), t-cell large granular lymphocytic leukemia, t-cell lymphoma, t-cell prolymphocytic leukemia